Neuropeptide Substance P Improves Osteoblastic and Angiogenic Differentiation Capacity of Bone Marrow Stem Cells In Vitro

Figure 1

Identify of BMSCs. The BMSCs were identified with CD29 (91.2%±1.3%), CD44 (88.4%±2.7%), CD34 (4.1%±1.9%), and CD45 (6.1%±2.5%).